Alpha 2.0
Login Register
» Articles » PMID: 23380330

Metabolic Syndrome (MetS) in Lebanese Patients with Schizophrenia Receiving Atypical Antipsychotic Drugs

Overview
Journal Asian J Psychiatr
Publisher Elsevier
Date 2013 Feb 6
PMID 23380330
Citations 3
Authors
R Bou Khalil
J Rohayem
N Abou Said
R El Chammay
R Haddad
S Richa
Affiliations
Soon will be listed here.
Citing Articles

Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway.

Liu X, Zhao X, Deng C, Zeng Y, Hu C Acta Pharmacol Sin. 2019; 40(8):1049-1057.

PMID: 30728467 PMC: 6786380. DOI: 10.1038/s41401-019-0212-1.

The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study.

Hammoudeh S, Ghuloum S, Mahfoud Z, Yehya A, Abdulhakam A, Al-Mujalli A BMC Psychiatry. 2018; 18(1):81.

PMID: 29587717 PMC: 5870932. DOI: 10.1186/s12888-018-1662-6.

Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats.

Liu X, Wu Z, Lian J, Hu C, Huang X, Deng C Sci Rep. 2017; 7(1):2762.

PMID: 28584269 PMC: 5459828. DOI: 10.1038/s41598-017-02884-w.